The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of RCL, MESO and LVS

The MarketWatch News Department was not involved in the creation of this content.

December 03, 2020 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / December 3, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Royal Caribbean Cruises Ltd. (NYSE:RCL)Class Period: February 4, 2020 – March 17, 2020Lead Plaintiff Deadline: December 7, 2020

The RCL lawsuit alleges Royal Caribbean Cruises Ltd. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) Royal Caribbean misled investors to believe that any issue related to COVID-19 was relatively insignificant; (2) the Company falsely assured investors that bookings outside China were strong with no signs of a slowdown; (3) the Company was experiencing material declines in bookings globally due to customer concerns over COVID-19; and (5) the Company’s ships were following grossly inadequate protocols that would foster the spread of COVID-19 and pose a substantial risk to passengers and crews.

Learn about your recoverable losses in RCL: http://www.kleinstocklaw.com/pslra-1/royal-caribbean-cruises-ltd-loss-submission-form?id=11352&from=1

Mesoblast Limited (NASDAQ:MESO)Class Period: April 16, 2019 – October 1, 2020Lead Plaintiff Deadline: December 7, 2020

Throughout the class period, Mesoblast Limited allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) comparative analyses between Mesoblast’s Phase 3 trial and three historical studies did not support the effectiveness of the Company’s lead product candidate, remestemcel-L, for steroid refractory acute graft versus host disease due to design differences between the four studies; (2) as a result, the US Food and Drug Administration was reasonably likely to require further clinical studies; (3) as a result, the commercialization of remestemcel-L in the U.S. was likely to be delayed; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in MESO: http://www.kleinstocklaw.com/pslra-1/mesoblast-limited-loss-submission-form?id=11352&from=1

Las Vegas Sands Corp. (NYSE:LVS)Class Period: February 27, 2016 – September 15, 2020Lead Plaintiff Deadline: December 21, 2020

The complaint alleges that during the class period Las Vegas Sands Corp. made materially false and/or misleading statements and/or failed to disclose that: (i) weaknesses existed in Marina Bay Sands’ casino control measures pertaining to fund transfers; (ii) the Marina Bay Sands’ casino was consequently prone to illicit fund transfers that implicated, among other issues, the transfer of customer funds to unauthorized persons and potential breaches in the Company’s anti-money laundering procedures; (iii) the foregoing foreseeably increased the risk of litigation against the Company, as well as investigation and increased oversight by regulatory authorities; (iv) Las Vegas Sands had inadequate disclosure controls and procedures; (v) consequently, all the foregoing issues were untimely disclosed; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in LVS: http://www.kleinstocklaw.com/pslra-1/las-vegas-sands-corp-loss-submission-form?id=11352&from=1

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:J. Klein, Esq.Empire State Building350 Fifth Avenue59th FloorNew York, NY [email protected]: (212) 616-4899Fax: (347) 558-9665www.kleinstocklaw.com

SOURCE: The Klein Law Firm

View source version on accesswire.com: https://www.accesswire.com/619460/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-RCL-MESO-and-LVS

COMTEX_375500901/2457/2020-12-03T19:13:25

Is there a problem with this press release? Contact the source provider Comtex at editoria[email protected] You can also contact MarketWatch Customer Service via our Customer Center.

Copyright 2020 ACCESSWIRE

The MarketWatch News Department was not involved in the creation of this content.

Source Article